Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000106363 | SCV001082908 | benign | Phenylketonuria | 2024-01-14 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003352770 | SCV004075588 | likely benign | Inborn genetic diseases | 2024-01-08 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Breakthrough Genomics, |
RCV004707941 | SCV005235501 | benign | not provided | criteria provided, single submitter | not provided | ||
Inserm U 954, |
RCV000106363 | SCV000143863 | probable-non-pathogenic | Phenylketonuria | no assertion criteria provided | not provided | Converted during submission to Likely benign. | |
Natera, |
RCV000106363 | SCV002088658 | likely benign | Phenylketonuria | 2020-04-17 | no assertion criteria provided | clinical testing |